E3 ubiquitin ligase NKLAM/RNF19b suppresses myc-driven B cell lymphomagenesis in Eμ-myc mice - Top-Institutions - MDSpire

E3 ubiquitin ligase NKLAM/RNF19b suppresses myc-driven B cell lymphomagenesis in Eμ-myc mice

  • By

  • Richard G. Hoover

  • Emily C. Matchett

  • Jacki Kornbluth

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Jackson Laboratory (JAX)
    Jackson Laboratory (JAX)

    Bar Harbor, Maine

    Key Differentiators

    • Hematology

  • #2

    Saint Louis University (SLU)
    Saint Louis University (SLU)

    Saint Louis, Missouri

    Key Differentiators

    • Hematology

  • #3

    Veterans Affairs (VA)
    Veterans Affairs (VA)

    Washington, D.C.

    Key Differentiators

    • Hematology

Original Source(s)

E3 ubiquitin ligase NKLAM/RNF19b suppresses myc-driven B cell lymphomagenesis in Eμ-myc mice

  • by Richard G. Hoover, Emily C. Matchett, Jacki Kornbluth

  • July 15, 2026

Related Content

Colorectal Cancer Treatment Delay Thresholds and Metastasis Risk

Functional convergence amid taxonomic variability in gut microbiome–immune checkpoint inhibitor research: a bibliometric and mechanistic synthesis

Surviving CGT's Funding Winter

In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market